NACB: 2014 Distinguished Abstracts Awards

The National Academy of Clinical Biochemistry is pleased to announce the winners of the 2014 Distinguished Abstracts Awards. A group of NACB Fellows selected these 34 abstracts for their scientific excellence from a pool of 873 abstracts accepted for the AACC Annual Meeting.

Winning abstracts will display the NACB blue ribbon during the AACC Annual Meeting poster sessions in Chicago, IL.

A-50 Chuan-xin Wang, Jinan, China
  Serum MicroRNA Panel as Biomarkers for Early Diagnosis of Colorectal Adenocarcinoma
A-53 Chunni Zhang, Nanjing, China
  MiR-28-5p, a potential biomarker for renal cell carcinoma, acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B
A-58 Jiri Polivka, Plzen, Czech Republic
  Prognostic Biomarker Isocitrate Dehydrogenase-1 Mutations in Patients with Glioblastoma Multiforme
A-63 Chuan-xin Wang, Jinan, China
  The upregulation of ICAM-1 mediated by leptin is Rho/ROCK-dependent and enhances gastric cancer cell migration
A-64 Philip Hemken, Abbott Park, IL
  hCG candidate epitopes for improving the measurement of hCG: results from the second ISOBM TD-7 workshop
A-66 John Mills, Rochester, MN
  High sensitivity detection of residual disease in multiple myeloma using mass spectrometry
A-67 Rula Abbud-Antaki, Allison Park, PA
  Identification of four molecular subclasses of Luminal Breast Cancer with different likelihood of recurrence and response to Tamoxifen
A-132 Yu Mu, Beijing, China
  Maternal Non-invasive Fetal DNA Test Used in Prenatal Diagnosis
A-146 Roberto Latini, Milan, Italy
  Circulating Presepsin (Soluble CD14 Subtype) in Patients with Severe Sepsis and Septic Shock. Data from the Albumin Italian Outcome Sepsis (ALBIOS) Study
A-148 Elizabeth Selvin, Baltimore, MD
  Diabetes, pre-diabetes and incidence of subclinical myocardial injury
A-150 Mikio Watanabe, Suita, Japan
  Different genotypes of a functional polymorphism of the TSHR gene are associated with the development and severity of Graves' and Hashimoto's diseases
A-151 Ioannis Papassotiriou, Athens, Greece
  Tubular Damage is Ubiquitous in Newly-Diagnosed Patients with Multiple Myeloma: Comparison of Three Urinary and Two Serum Markers of Kidney Injury
A-220 Julia Botelho, Atlanta, GA
  CDC Standardization Programs- Testosterone, Estradiol, and Vitamin
A-232 Tiedong Guo, Willow Grove, PA
  Rapid and Cost-effective Determination of Plasma Renin Activity in Human EDTA Plasma by Two Dimensional Liquid Chromatography-Tandem Mass Spectrometry
A-316 Ozge Cevik, Sivas, Turkey
  Proteomic profiling of platelets in acute ischemic stroke patients
A-321 Juana Jimenez, Madrid, Spain
  Risk Stratification and Progression follow-up of MGUS Patients: value of the sFLC and Heavy Chain/Light Chain Pairs markers
A-372 Jiri Polivka, Plzen, Czech Republic
  Multiplex Assay of Circulating Inflammatory Biomarkers in Patients with Stroke
A-426 Qingwei Ma, Beijing, China
  Identifying four serum peptides as biomarkers for T2DM early diagnosis by MALDI-TOF MS
B-32 Christopher McCudden, Ottawa, ON, Canada
  Identification of Erroneous Potassium Results Using a Laboratory Data-Derived Machine Learning Algorithm
B-34 Roxanne Ybabez, Rochester, MN
  Moving Patient Averages: A Pilot Study Using Error Simulation
B-120 Irina Kirpich, Louisville, KY
  Saturated and unsaturated dietary fat differentially modulate ethanol-mediated changes in gut microbiome, intestinal barrier integrity and liver in an experimental animal model of alcoholic liver disease
B-172 Natalia Rush, Indianapolis, IN
  Eliminating non-value added pre-analytic processes to improve laboratory turnaround time and patient safety for emergency room patients
B-266 Ann Gronowski, St. Louis, MO
  Development of a Pregnant Subject Biospecimen Bank
B-272 Linda Hasadsri, Rochester, MN
  Diagnosis of Primary Hyperoxaluria Type III, A Novel Hereditary Disorder of Hydroxyproline Metabolism, By Gas Chromatography-Mass Spectrometry
B-273 Man Khun Chan, Toronto, ON, Canada
  Pediatric reference intervals for specialty endocrine and chemistry biomarkers on the Abbott Architect ci4100 System: A CALIPER study of healthy community children
B-346 Paul Collinson, London, UK
  The value of delta troponin for differential diagnosis of troponin elevation in non AMI patients in the unselected emergency room population.
B-349 Olaia Rodriguez Fraga, Madrid, Spain
  Cardiac Troponin Testing Is Over Utilized in Patient Care to Rule In and Rule Out Myocardial Infarction
B-350 Yang Luo, Changqing, China
  Development and validation of a X-ray fluorescence method for ischemia-modified protein detection
B-353 Colleen Shortt, Mississauga, ON, Canada
  Myocardial injury in cancer patients - are there differences between women and men?
B-358 Jillian Tate, Brisbane, Australia
  Evaluation of standardization capability of current cardiac troponin I (cTnI) assays by a correlation study: results of an IFCC pilot project
B-362 George Cembrowski, Edmonton, AB, Canada
  Magnitude of short- and long-term intra-patient BNP variation in low BNP patients: Implications for more rational BNP utilization
B-379 M. Veitinger, Crumlin, UK
  Biochip Array Technology Rapidly Identifies a Platelet-Derived Alzheimer's Disease-Specific Phenotype
B-426 Courtney Heideloff, Cleveland, OH
  Formation of 6-monoaetylmorphine in urine specimens with high morphine concentrations during enzymatic hydrolysis
B-432 Katie Thoren, San Francisco, CA
  Development of a comprehensive drug screen in urine using liquid-chromatography quadrupole time of flight mass spectrometry.
Page Access: